Enzymes biotechnology / by 521752 Gray, N., Calvin, M., Bhatia, S. C.

A qualitative exploration of the role of primary care in supporting colorectal cancer patients by Hall, S, Gray, N, Browne, S, Ziebland, S, Campbell, N

A qualitative exploration of the role of primary care in supporting colorectal cancer patients. by Hall, S, Gray, N, Browne, S, Ziebland, S, Campbell, N

Intergovernmental dynamics in responding to COVID-19 in English and Australian cities by Broadhurst, K, Gray, N, Mykhnenko, V, Steane, E

SCHIZ BITS - MISSES, MYSTERIES AND HITS by Gray, J, Hemsley, D, Feldon, J, Gray, N, Rawlins, J

Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts by Majkowska, I, Shitomi, Y, Ito, N, Gray, N, Itoh, Y

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors by Canning, P, Tan, L, Chu, K, Lee, S, Gray, N, Bullock, A

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors. by Canning, P, Tan, L, Chu, K, Lee, S, Gray, N, Bullock, A

Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution by Gray, N, Cheung, C-KJ, Khalil, A, O'Sullivan, J, Psaila, B

A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. by Chaikuad, A, Tacconi, E, Zimmer, J, Liang, Y, Gray, N, Tarsounas, M, Knapp, S

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery? by Zhao, Z, Wu, H, Wang, L, Liu, Y, Knapp, S, Liu, Q, Gray, N

Research shapes policy: but the dynamics are subtle by Foy, R, Locock, L, Purdy, S, O'Donnell, C, Gray, N, Doran, T, Davies, H

Council housing: Time to invest (now, more than ever), submission of evidence to the All Party Parliamentary Group for Council Housing by Dorling, D, Goulding, R, Gray, N, Hodkinson, S, Penny, J, Robbins, G, Smyth, S, Watt, P

SCL establishes a transcriptional and epigenetic repressive environment in blood-fated cells to suppress alternative mesodermal lineages by Porcher, C, Chagraoui, H, Kristiansen, M, Richter, J, Gray, N, Repapi, E, Taylor, S, Vyas, P

A cross-sectional study of patient-reported outcomes of individuals with X-linked hypophosphataemia within the UK by Cole, S, Sanchez-Santos, MT, Barrett, J, Gray, N, Turner, T, Kolovos, S, Javaid, MK, Pinedo Villanueva, R

Change in patient-reported outcomes of XLH registry participants in the UK: a longitudinal study by Cole, S, Gray, N, Barrett, J, Turner, A, Sanchez-Santos, MT, Kolovos, S, Javaid, MK, Pinedo-Villanueva, R

Patient-reported outcomes of X-linked hypophosphataemia registry participants in the UK by Cole, S, Sanchez-Santos, MT, Barrett, J, Gray, N, Turner, A, Kolovos, S, Javaid, M, Pinedo-Villanueva, R

A longitudinal study of patient-reported outcomes of RUDY registry participants with X-linked hypophosphataemia in the UK by Cole, S, Gray, N, Barrett, J, Turner, A, Sanchez-Santos, MT, Kolovos, S, Javaid, MK, Pinedo Villanueva, R

No evidence for age-related differences in mtRNA quality in the female germline by Hartley, FM, Alageel, A, Appeltant, R, Gray, N, Repapi, E, Wells, D, Williams, SA, Poulton, J

X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor. by Elkins, J, Wang, J, Deng, X, Pattison, M, Arthur, J, Erazo, T, Gomez, N, Lizcano, J, Gray, N, Knapp, S